154 related articles for article (PubMed ID: 9030704)
1. Isoform-specific binding of human apolipoprotein E to the non-amyloid beta component of Alzheimer's disease amyloid.
Olesen OF; Mikkelsen JD; Gerdes C; Jensen PH
Brain Res Mol Brain Res; 1997 Feb; 44(1):105-12. PubMed ID: 9030704
[TBL] [Abstract][Full Text] [Related]
2. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
Strittmatter WJ; Weisgraber KH; Huang DY; Dong LM; Salvesen GS; Pericak-Vance M; Schmechel D; Saunders AM; Goldgaber D; Roses AD
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8098-102. PubMed ID: 8367470
[TBL] [Abstract][Full Text] [Related]
3. Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid.
LaDu MJ; Pederson TM; Frail DE; Reardon CA; Getz GS; Falduto MT
J Biol Chem; 1995 Apr; 270(16):9039-42. PubMed ID: 7721816
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.
Sanan DA; Weisgraber KH; Russell SJ; Mahley RW; Huang D; Saunders A; Schmechel D; Wisniewski T; Frangione B; Roses AD
J Clin Invest; 1994 Aug; 94(2):860-9. PubMed ID: 8040342
[TBL] [Abstract][Full Text] [Related]
5. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
6. [Lipoproteins in clinical laboratory medicine].
Kuriyama M
Rinsho Byori; 1998 Dec; 46(12):1219-25. PubMed ID: 9916507
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
[TBL] [Abstract][Full Text] [Related]
8. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.
Castano EM; Prelli F; Wisniewski T; Golabek A; Kumar RA; Soto C; Frangione B
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):599-604. PubMed ID: 7534068
[TBL] [Abstract][Full Text] [Related]
9. ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA.
Yajima R; Tokutake T; Koyama A; Kasuga K; Tezuka T; Nishizawa M; Ikeuchi T
Biochem Biophys Res Commun; 2015 Jan; 456(1):482-8. PubMed ID: 25482438
[TBL] [Abstract][Full Text] [Related]
10. The interaction of amyloid-beta with ApoE.
Carter DB
Subcell Biochem; 2005; 38():255-72. PubMed ID: 15709483
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease amyloid-beta peptide modulates apolipoprotein E isoform specific receptor binding.
Hone E; Martins IJ; Jeoung M; Ji TH; Gandy SE; Martins RN
J Alzheimers Dis; 2005 Aug; 7(4):303-14. PubMed ID: 16131732
[TBL] [Abstract][Full Text] [Related]
12. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides.
Tokuda T; Calero M; Matsubara E; Vidal R; Kumar A; Permanne B; Zlokovic B; Smith JD; Ladu MJ; Rostagno A; Frangione B; Ghiso J
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):359-65. PubMed ID: 10816430
[TBL] [Abstract][Full Text] [Related]
13. Isoform-specific binding of apolipoprotein E to beta-amyloid.
LaDu MJ; Falduto MT; Manelli AM; Reardon CA; Getz GS; Frail DE
J Biol Chem; 1994 Sep; 269(38):23403-6. PubMed ID: 8089103
[TBL] [Abstract][Full Text] [Related]
14. Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier.
Zlokovic BV
Life Sci; 1996; 59(18):1483-97. PubMed ID: 8890929
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.
Bentley NM; Ladu MJ; Rajan C; Getz GS; Reardon CA
Biochem J; 2002 Aug; 366(Pt 1):273-9. PubMed ID: 12015813
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E forms stable complexes with recombinant Alzheimer's disease beta-amyloid precursor protein.
Haas C; Cazorla P; Miguel CD; Valdivieso F; Vázquez J
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):169-75. PubMed ID: 9224643
[TBL] [Abstract][Full Text] [Related]
17. The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation.
Golabek AA; Soto C; Vogel T; Wisniewski T
J Biol Chem; 1996 May; 271(18):10602-6. PubMed ID: 8631862
[TBL] [Abstract][Full Text] [Related]
18. Human cerebrospinal fluid apolipoprotein E isoforms are apparently inefficient at complexing with synthetic Alzheimer's amyloid-[beta] peptide (A[beta] 1-40 ) in vitro.
Zhou Z; Relkin N; Ghiso J; Smith JD; Gandy S
Mol Med; 2002 Jul; 8(7):376-81. PubMed ID: 12393935
[TBL] [Abstract][Full Text] [Related]
19. Association of human, rat, and rabbit apolipoprotein E with beta-amyloid.
LaDu MJ; Lukens JR; Reardon CA; Getz GS
J Neurosci Res; 1997 Jul; 49(1):9-18. PubMed ID: 9211985
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L. Implications for amyloidogenesis and Alzheimer's disease.
Castaño EM; Prelli F; Pras M; Frangione B
J Biol Chem; 1995 Jul; 270(29):17610-5. PubMed ID: 7615568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
